AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...
Rolling Out3h
How your genes secretly shape your brain and health
Genes shape brain structure and may influence neurological disorders like Parkinson’s and ADHD, revealing new insights into brain health.
Morningstar3d
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy
“The RMAT designation for AB-1005 underscores the high unmet medical need and the potential of this investigational gene therapy to make a difference for patients with Parkinson’s disease ...
Medical News Today16h
What one man's 'escape' from Alzheimer's might tell us about the disease
A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...
The Pharma Letter2d
AskBio wins FDA RMAT designation for Parkinson’s gene therapy
Germany-based Bayer’s wholly-owned gene therapy company AskBio today announced that its investigational gene therapy AB-1005 ...
Yahoo Finance3d
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy
investigational gene therapy for the treatment of moderate-stage Parkinson’s disease AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer ...
Ibogaine by David Dardashti Explores Groundbreaking Research Linking Genetic Enhancers to Neurological Disease Treatment, Including Parkinson’s
Ibogaine by David Dardashti, a leading voice in the exploration of ibogaine's therapeutic potential, is closely analyzing a new study published in EMBO Reports that sheds light on the intricate ...
Parkinson’s Disease: The long-awaited early detection technique is on the horizon
John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...
BioTechniques22h
Novel enhancers linked to Parkinson’s and schizophrenia
A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.
Pharmabiz2d
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...
中国日报网1d
Target protein could slow progression of Parkinson's
Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first ...